FairValu
Merck & Co., Inc.

Merck & Co., Inc.

MRKNYSE
Drug Manufacturers - General • Healthcare•merck.com
Current Price
$145.950.00%
Market Cap
$360.08B
Shares Outstanding: 2.47B
Volume
-
Avg Vol (3M): -
Next Earnings
-
52 Week Range
Low: $--High: $--
SummaryResearchChartsSEC Filings

Latest results at a glance

Insights from the latest company results and reports · filed 4 Aug 2026

  • EPS Beats Consensus

    Reported non-GAAP EPS of $-0.13 per share for the second quarter of 2026 exceeded the consensus estimate of $-0.26 per share.

  • Winrevair Revenue Surge

    Winrevair revenue reached $522.0 million, up 61.6% from the prior year period, contributing 3.1% to total consolidated revenue.

  • Updated Earnings Outlook

    The company lowered its full-year 2026 non-GAAP EPS guidance to a range of $2.66 to $2.76, incorporating $2.43 per share in charges related to the Terns acquisition.

AI-generated · updated 2 Oct 2026View source filing

Company research evidence

Checked financial measurements with the values, reporting periods and measurement basis shown together. This evidence is available independently of the AI report.

Loading evidence…

Deep Dive Research

Source-linked company research for MRK

Revenue segmentation

Loading segment disclosures…